# Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination

> **NCT02485912** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 40 (actual)

## Conditions studied

- Ebola Virus Disease

## Interventions

- **BIOLOGICAL:** ChAd3-EBO Z
- **BIOLOGICAL:** MVA-EBO Z

## Key facts

- **NCT ID:** NCT02485912
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02485912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02485912, "Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02485912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*